Open for inclusion

Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

Cancer type: Lung cancer, Melanoma

Phase: I/II

Principal Investigator: Nyakas Martha

Country: NO

Keywords: Norway, Oslo, Advanced solid tumors, BMS-986218, Nivolumab and Ipilimumab

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03110107?term=CA022-001&draw=2&rank=1